Image

Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission

Study on Ritlecitinib's safety for celiac patients in remission.

Recruiting
18-75 years
All
Phase 2
This study is testing a medicine called **ritlecitinib** on people with **Celiac Disease (CeD)**, a condition where the body reacts badly to gluten, a protein in wheat. Participants must be 18 to 75 years old, have inactive CeD, and have been on a gluten-free diet for at least 6 months. They will take either ritlecitinib or a placebo (a fake pill) once a day. Everyone will also eat 10g of gluten each day for 21 days, mixed into food like hot chocolate or apple sauce. If 10g is too much, participants can switch to 5g after the third day. - **Duration:** Study lasts for 21 days with daily medication and gluten consumption. - **Visits/Tests:** Participants need a negative COVID test before starting and two more before endoscopy (a test to look inside the stomach). - **Important Considerations:** Participants must avoid strenuous exercise, excessive grapefruit juice, and use effective birth control if needed.
Study details
    Celiac Disease

NCT05636293

Massachusetts General Hospital

17 April 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.